Back to results
US 2003/0119832 A1Published application
Treatment of ocular disorders
AssigneeNovartis AG
InventorDavid Goldblum
Life of this patent
Estimating the term…
Abstract
The present invention is in particular related to the use of rivastigmine in the manufacture of a medicament for the treatment of ocular disorders.
Claims10
Use of a compound of formula (I),
- 4
- wherein
- R1 is hydrogen, lower alkyl, cyclohexyl, allyl or benzyl,
- R2 is hydrogen, methyl, ethyl or propyl or
- R1 and R2 together with the nitrogen to which they are attached form a morpholino or piperidino radical,
- R3 is hydrogen or lower alkyl,
- R4 and R5 are the same or different and each is a lower alkyl, and the dialkylaminoalkyl group is in the meta, ortho or para position,
- in free base or pharmaceutically acceptable acid addition salt form,
- in the preparation of a pharmaceutical composition for the treatment of an ocular disorder selected from the group consisting of glaucoma, normal tension glaucoma and neurodegenerative disease conditions of the retina and the optic nerve.
6 more elements
Method of treating an ocular disorder, which disorder is selected from the group consisting of glaucoma, normal tension glaucoma and neurodegenerative disease conditions of the retina and the optic nerve, which method comprises the repeated administration of a pharmaceutically effective amount of a compound of any one of the preceeding claims to an individual in need of such treatment.
Dependencies are inferred from the claim text.